Trial intelligence / Profile preview

Sodium valproate in paediatric and adult patients with Wolfram syndrome

2017-001215-37Phase 2Unknown

Sponsor
University of Birmingham
Start
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of valproic acid in Wolfram syndrome (2 arms), sponsored by University of Birmingham. Primary endpoint: Rate of change in visual acuity. Status: unknown.

02

Drugs

valproic acid
03

Conditions

Wolfram syndrome

Beyond the preview

Go deeper on 2017-001215-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-001215-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call